Home » Our work » Medicines Management » Policies, guidelines & Resource documents » Clinical Guidelines, Medicines Optimisation Commissioning Policies and Resources » Drugs of Limited Clinical Value (DoLCV)
Back to 'Clinical Guidelines, Medicines Optimisation Commissioning Policies and Resources'
Page last updated 21 June 2021